Description:

BMRN is the ticker symbol for BioMarin Pharmaceutical Inc., a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company specializes in developing and commercializing innovative therapies for serious rare genetic diseases. With a strong focus on genetic research and development, BioMarin aims to address unmet medical needs by creating targeted treatments that can significantly improve patients' lives. Its portfolio includes a range of products and investigational compounds designed to treat conditions such as phenylketonuria (PKU), Hunter syndrome, and hemophilia A, among others.

Data:

Yields: